ReNerve study shows major patient outcome benefits of NervAlign nerve cuff

Advanced nerve repair and regeneration solutions specialist ReNerve (ASX: RNV) has identified significant benefits for patient outcomes when using its NervAlign Nerve Cuff technology.

A recent study found that patients undergoing peripheral nerve surgery with the NervAlign Nerve Cuff experienced a major decrease in post-surgery pain measures compared to surgery in which the product was not used.

The investigation also found that average post-operative pain scores decreased from 7.1 to 0.4 with the Nerve Cuff, compared to a reduction from 7.1 to 3.3 without it.

Regenerating nerves

ReNerv developed the NervAlign Nerve Cuff to help protect repaired and regenerating nerves during the healing process after peripheral nerve injuries or surgery.

NervAlign is naturally absorbed into the body within six months, leaving only regenerated and repaired tissue.

The study – presented this week at the American College of Foot and Ankle Surgeons annual conference in Arizona – also found that patients treated with the Nerve Cuff reported higher satisfaction with their surgery compared to those who did not receive the Nerve Cuff.

93% of the former said they would elect to have surgery again, as opposed to 70% of the latter.

Significant results

ReNerve chief executive officer Dr Julian Chick said that the medical properties of the NervAlign Nerve Cuff make it suitable for use in a wide range of surgical procedures.

“These are very significant results for the development of ReNerve’s products, as they highlight the utility of the NervAlign Nerve Cuff in reducing patients’ pain following peripheral nerve surgery,” Dr Chick said.

“The results clearly demonstrate the patient benefits that follow from the proper repair and regeneration of a nerve that is returned to normal function post-surgery.”

“The NervAlign Nerve Cuff facilitates the patient’s repair process and protects it during the initial post-operative recovery and regeneration period.”